&nbsp;

YVM_FAQ_Staff.docx

Sep 2021

Document

YVM_FAQ_Staff-FR.docx

Sep 2021

Document

YVMSurvey_Inperson_Print.docx

Sep 2021

Document

YVMSurvey_Inperson_Print-FR.docx

Sep 2021

Document

YVMSurvey_televid_Print.docx

Sep 2021

Document

YVMSurvey_televid_Print-FR.docx

Sep 2021

Regimen

PRLS

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Drugs Used:

pralsetinib (Unfunded)

Quick Link(s):

Regimen Monograph

Oct 2021

Regimen

PEMB

Cancer Type:

Genitourinary,

Renal cell / Kidney

Intent: Adjuvant

Funding:

New Drug Funding Program

Pembrolizumab - Adjuvant Treatment for Renal Cell Carcinoma

Drugs Used:

pembrolizumab

Quick Link(s):

Regimen Monograph

Sep 2025

Regimen

PACL(W)+PEMB

Cancer Type:

Breast

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Locally Recurrent Unresectable or Metastatic Triple Negative Breast Cancer

Drugs Used:

pembrolizumab,

PACLitaxel

Quick Link(s):

Regimen Monograph

Sep 2023

Document

PCC_4233_FN_CancerScreeningGuide.pdf

Nov 2021

Document

PCC_4233_FN_CancerScreeningGuide_FR.pdf

Nov 2021

Regimen

PEMB(MNT)

Cancer Type:

Gynecologic,

Cervix

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Metastatic, Persistent, or Recurrent Carcinoma of the Cervix

Drugs Used:

pembrolizumab